ImmunityBio Shares Rise Nearly 1% as Founder Promotes Sepsis Research
ImmunityBio shares climbed nearly 1% overnight as founder Patrick Soon-Shiong highlighted plans to test its immunotherapy in sepsis. He also renewed a teaser about NantX; the report provides no launch timing or further details.
Shares of ImmunityBio (IBRX) climbed nearly 1% overnight heading into Tuesday as founder Patrick Soon-Shiong highlighted plans to test its immunotherapy in sepsis, raising interest in Anktiva’s potential beyond cancer, while renewing his “NantX coming soon” teaser after a massive crypto theft.IBRX…